Primary Site >> Liver Cancer
Gene >> S100A9
|
|
|
|
|
|---|---|---|---|---|
|
Ref: Immunohistochemical investigation of S100A9 expression in pulmonary adenocarcinoma: S100A9 expression is associated with tumor differentiation. PMID: 11295086 |
Ref: S100A9 expression in invasive ductal carcinoma of the breast: S100A9 expression in adenocarcinoma is closely associated with poor tumour differentiation. PMID: 15110881 |
Ref: Actein activates stress- and statin-associated responses and is bioavailable in Sprague-Dawley rats. PMID: 19527300 Ref: S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. PMID: 19670424 |
Ref: Proteomic analysis of the role of S-nitrosoglutathione reductase in lipopolysaccharide-challenged mice. PMID: 22623366 |
Ref: S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway. PMID: 23354417 Ref: Development and characterization of a reliable mouse model of colorectal cancer metastasis to the liver. PMID: 23748471 |